Education
About Us
Working with TipRanks
Follow Us
Therapeuticsmd Inc (TXMD)
:TXMD
TXMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.70 - $2.44
Previous CloseN/A
Volume92.69K
Average Volume (3M)20.50K
Market Cap
$12.85M
Enterprise Value$13.96M
Total Cash (Recent Filing)$6.07M
Total Debt (Recent Filing)$5.72M
Price to Earnings (P/E)―
Beta1.60
Next Earnings
Nov 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding11,574,362
10 Day Avg. Volume13,012
30 Day Avg. Volume20,497
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue5.46
Enterprise Value/Gross Profit5.91
Enterprise Value/Ebitda-10.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TherapeuticsMD News
TXMD FAQ
What was Therapeuticsmd Inc’s price range in the past 12 months?
Therapeuticsmd Inc lowest stock price was $0.70 and its highest was $2.44 in the past 12 months.
What is Therapeuticsmd Inc’s market cap?
Therapeuticsmd Inc’s market cap is $12.85M.
When is Therapeuticsmd Inc’s upcoming earnings report date?
Therapeuticsmd Inc’s upcoming earnings report date is Nov 17, 2025 which is in 74 days.
How were Therapeuticsmd Inc’s earnings last quarter?
Therapeuticsmd Inc released its earnings results on Aug 12, 2025. The company reported $0.048 earnings per share for the quarter, beating the consensus estimate of N/A by $0.048.
Is Therapeuticsmd Inc overvalued?
According to Wall Street analysts Therapeuticsmd Inc’s price is currently Overvalued.
Does Therapeuticsmd Inc pay dividends?
Therapeuticsmd Inc does not currently pay dividends.
What is Therapeuticsmd Inc’s EPS estimate?
Therapeuticsmd Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Therapeuticsmd Inc have?
Therapeuticsmd Inc has 11,574,362 shares outstanding.
What happened to Therapeuticsmd Inc’s price movement after its last earnings report?
Therapeuticsmd Inc reported an EPS of $0.048 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Therapeuticsmd Inc?
Currently, no hedge funds are holding shares in TXMD
Company Description
Therapeuticsmd Inc
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Technical Analysis
Prophase Labs
―
Aytu BioScience
―
Kala Pharmaceuticals
―
Cosmos Holdings
―
Biofrontera
―
Ownership Overview
1.48% Insiders
4.48% Mutual Funds
21.07% Other Institutional Investors
70.13% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---